Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (17878)	3/25/1998 11:34:00 PM
From: shasta23	Read Replies (4) \| Respond to of 32384

Sounds good Henry...the stocks needs some right-left punches right into the face of new investors. I guess that most of the oldtimers are already loaded with the stock and it now represents a big chunk %agewise in their portfolio(like mine) so that adding here seems not advised. So you need fresh blood that will be pulled in from the outside and all these news releases will hopefully do some job. A little more institutional buying would also be nice.I'm holding this stock for the long term but hope we would break out of that 11-18 range once and for all! GO LGND... Stefan

To: Henry Niman who wrote (17878)	3/26/1998 12:42:00 PM
From: tuck	Read Replies (1) \| Respond to of 32384

Henry, You wrote: " A new alliance or two would also come as no surprise. In fact I would be surprised if one or two were not announced fairly soon." Would you care to expand on this a tad? What in the pipeline is left to negotiate with that doesn't have to do with Ligand's core businesses (cancer, female health, and (drat, I think it's) metabolic disease)? By the way, you remember our little debate about rexinoids and triglycerides? I'm told the serum levels jump briefly but sharply after each dose. Transient, yes, but a daily problem. I am told it's the chief downside to the compounds (others didn't exist or were to minor to merit comment, apparently). Regards, Tuck